Activation of Autoreactive B Cells by CpG dsDNA

Immunity

Volumn 19, Issue 6, 2003, Pages 837-847

  Viglianti, Gregory A ^a   Lau, Christina M ^a   Hanley, Timothy M ^a   Miko, Benjamin A ^a   Shlomchik, Mark J ^b   Marshak Rothstein, Ann ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; DNA FRAGMENT; DOUBLE STRANDED DNA; HAPTEN ANTIBODY; RHEUMATOID FACTOR; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF;

EID: 0347480224     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00323-6     Document Type: Article

References (41)

1. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. Bacterial CpG-DNA and liposaccharides activate Toll-like receptors at distinct compartments. Eur. J. Immunol. 32:2002;1958-1968.
2. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recogniton. Proc. Natl. Acad. Sci. USA. 98:2001;9237-9242.
3. Cohen P.L., Eisenberg R.A. Lpr and gld. single gene models of systemic autoimmunity and lymphoproliferative disease Annu. Rev. Immunol. 9:1991;243-269.
4. Cross S.H., Bird A.P. CpG islands and genes. Curr. Opin. Genet. Dev. 5:1995;309-314.
5. Cross S.H., Lee M., Clark V.H., Craig J.M., Bird A.P., Bockmore W.A. The chromosomal distribution of CpG islands in the mouse. evidence for genome scrambling in the rodent lineage Genomics. 40:1997;454-461.
6. Dal Porto J.M., Haberman A.M., Kelsoe G., Shlomchik M.J. Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J. Exp. Med. 195:2002;1215-1221.
7. Dal Porto J.M., Haberman A.M., Shlomchik M.J., Kelsoe G. Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. J. Immunol. 161:1998;5373-5381.
8. Dongworth D.W., Klaus G.G. Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies. Eur. J. Immunol. 12:1982;1018-1022.
9. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. measures and values J. Mol. Biol. 196:1987;261-282.
10. Goeckeritz B.E., Flora M., Witherspoon K., Vos Q., Lees A., Dennis G.J., Pisetsky D.S., Klinman D.M., Snapper C.M., Mond J.J. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotides motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int. Immunol. 11:1999;1693-1700.
11. Hannum L.G., Ni D., Haberman A.M., Weigert M.G., Shlomchik M.J. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse. implications for the origins of autoantibodies in autoimmune disease J. Exp. Med. 184:1996;1269-1278.
12. Hannum L.G., Haberman A.M., Anderson S.M., Shlomchik M.J. Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J. Exp. Med. 192:2000;931-942.
13. Heit A., Maurer T., Hochrein H., Bauer S., Huster K.M., Busch D.H., Wagner H. Cutting edge. Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells J. Immunol. 170:2003;2802-2805.
14. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
15. Ishii K.J., Suzuki K., Coban C., Takeshita F., Itoh Y., Matoba H., Kohn L.D., Klinman D.M. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167:2001;2602-2607.
16. Jacobson B.A., Sharon J., Shan H., Shlomchik M., Weigert M.G., Marshak-Rothstein A. An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. J. Immunol. 152:1994;4489-4499.
17. Karlin S., Ladunga I., Blaisdell B.E. Heterogeneity of genomes. measures and values Proc. Natl. Acad. Sci. USA. 91:1994;12837-12841.
18. Kotzin B.L. Systemic lupus erythematosus. Cell. 85:1996;303-306.
19. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:2002;709-760.
20. Krieg A.M., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretsky G.A., Klinman D. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
21. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., Yi A.-K., Short D., Davis H.L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA. 95:1998;631-636.
22. Krystosek A. Preferential sites of early DNA cleavage in apoptosis and the pathway of nuclear damage. Histochem. Cell Biol. 111:1999;265-276.
23. Leadbetter E.A., Rifkin I.R., Hohlbaum A.H., Beaudette B., Shlomchik M.J., Marshak-Rothstein A. Immune complexes activate autoreactive B cells by co-engagement of sIgM and Toll-like receptors. Nature. 419:2002;603-607.
24. Lenart P., Stunz L., Yi A.-K., Krieg A.M., Ashman R.F. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev. 4:2001;247-256.
25. Mandik-Nayak L., Bui A., Noorchashm H., Eaton A., Erikson J. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice. localization to the T-B interface of the splenic follicle J. Exp. Med. 186:1997;1-11.
26. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147:1991;1759-1764.
27. Monestier M., Novick K.E. Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. Mol. Immunol. 33:1996;89-99.
28. Plotz P.H. The autoantibody repertoire. searching for order Nat. Rev. Immunol. 3:2003;73-78.
29. Radic M.Z., Mascelli M.A., Erikson J., Shan H., Weigert M. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146:1991;176-182.
30. Roark J.H., Kuntz C.L., Nguyen K.A., Caton A.J., Erikson J. Breakdown of B cell tolerance in a mouse model of Systemic Lupus Erythematosus. J. Exp. Med. 181:1995;1157-1167.
31. Rui L., Vinusa C.G., Blasioli J., Goodnow C.C. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4:2003;594-600.
32. Sano H., Morimoto C. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J. Immunol. 128:1982;1341-1345.
33. Shlomchik M.J., Aucoin A.H., Pisetsky D.S., Weigert M.G. Structure and fundtion of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA. 84:1987;9150-9154.
34. Song W., Cho H., Cheng P., Pierce S.K. Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking. J. Immunol. 155:1995;4255-4263.
35. Wang H., Shlomchik M. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159:1997;1125-1134.
36. Wang H., Shlomchik M.J. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190:1999;639-649.
37. Wang Y., Krieg A.M. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int. Immunol. 15:2003;223-231.
38. William J., Euler C., Christensen S., Shlomchik M.J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 297:2002;2066-2070.
39. Wolfowicz C.B., Sakorafas P., Rothstein T.L., Marshak-Rothstein A. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin. Immunol. Immunopath. 46:1988;382-395.
40. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells, and inhibits tumor growth. Microbiol. Immunol. 36:1992;983-997.
41. Zhu F.-G., Reich C.F., Pisetsky D.S. Effect of cytofectins on the immune response of murine macrophages to mammalian DNA. Immunol. 109:2003;255-262.